Juri Alessandro Giannotta, Medical Doctor

MD
Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico, Angelo Bianchi Bonomi Hemophilia and Thrombosis Center, Milan, Italy
Milano, Lombardia, Italy

Juri Alessandro Giannotta, MD, “Angelo Bianchi Bonomi” Haemophilia and Thrombosis Centre, IRCCS Foundation Ca' Granda Ospedale Maggiore Policlinico, Milan (Italy)
Since my years as a trainee in clinical hematology, I developed a particular interest for autoimmune blood diseases. I dedicated myself to autoimmune cytopenias and, more recently, I joined the “Angelo Bianchi Bonomi” Haemophilia and Thrombosis Centre, where I treat patients with venous thromboembolism, platelet disorders and thrombotic microangiopathies.

Presentation(s):

• OC 26.2 - Bortezomib for rituximab-refractory immune-mediated thrombotic thrombocytopenic purpura in the caplacizumab era: update of an Italian multicenter study

  Sunday, June 23, 2024
  15:00 – 15:15 ICT

• OC 26.5 - Predisposing conditions and drugs to caplacizumab-related bleeding episodes in patients with acute immune-mediated TTP: real-world data from the Milan Center

  Sunday, June 23, 2024
  15:45 – 16:00 ICT

• PB1326 - Clinical severity of the first episode and risk of recurrent neurological symptoms in relapses among patients with immune-mediated thrombotic thrombocytopenic purpura

  Tuesday, June 25, 2024
  13:45 – 14:45 ICT

• OC 66.5 - Antithrombotic prophylaxis following inferior vena cava replacement with cryopreserved aortic homograft for primary leiomyosarcoma: a cohort study

  Tuesday, June 25, 2024
  15:45 – 16:00 ICT